Journal
CELL METABOLISM
Volume 6, Issue 3, Pages 208-216Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2007.08.006
Keywords
-
Categories
Funding
- NIDDK NIH HHS [DK63068, DK57539] Funding Source: Medline
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The hallmark of type 2 diabetes is excessive hepatic glucose production. Several transcription factors and coactivators regulate this process in cultured cells. But gene ablation experiments have yielded few clues as to the physiologic mediators of this process in vivo. We show that inactivation of the gene encoding forkhead protein Foxo1 in mouse liver results in 40% reduction of glucose levels at birth and 30% reduction in adult mice after a 48 hr fast. Gene expression and glucose clamp studies demonstrate that Foxo1 ablation impairs fasting- and cAMP-induced glycogenolysis; and gluconeogenesis. Pgcl alpha is unable to induce gluconeogenesis in Foxol-deficient hepatocytes, while the cAMP response is significantly blunted. Conversely, Foxol deletion in liver curtails excessive glucose production caused by generalized ablation of insulin receptors and prevents neonatal diabetes and hepatosteatosis in insulin receptor knockout mice. The data provide a unifying mechanism for regulation of hepatic glucose production by cAMP and insulin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available